WNS Signs Contract Extension with Leading Pharmaceutical Company for High-End Research & Analytics Services
April 29 2013 - 6:33AM
Business Wire
WNS (Holdings) Limited (NYSE: WNS), a leading provider of global
Business Process Outsourcing (BPO) services, announced today that
it has extended its contract with global pharmaceutical leader
GlaxoSmithKline Services Unlimited (GSK), to deliver high-end
research and analytics services.
"In a rapidly changing and increasingly competitive global
economy, the ability to analyze large amounts of complex data to
drive insight-based decisions is critical to success. WNS has been
a trusted partner in delivering these high-value analytics
solutions to GSK, and we are delighted to announce this contract
extension with a recognized leader in the pharmaceutical industry,”
said Keshav R. Murugesh, Group CEO, WNS Global Services.
WNS enables its global clients to make critical business
decisions leveraging its research and analytics expertise, deep
industry knowledge and robust delivery capabilities. WNS currently
has over 2,000 research and analytics professionals supporting
areas such as customer lifecycle analytics, market and business
research, strategy and decision support, demand forecasting,
customer risk scoring, loss management modeling, and measurement
and reporting.
About WNSWNS (Holdings)
Limited (NYSE: WNS), is a leading global business process
outsourcing company. WNS offers business value to 200+ global
clients by combining operational excellence with deep domain
expertise in key industry verticals including Travel, Insurance,
Banking and Financial Services, Manufacturing, Retail and Consumer
Packaged Goods, Shipping and Logistics and Healthcare and
Utilities. WNS delivers an entire spectrum of business process
outsourcing services such as finance and accounting, customer care,
technology solutions, research and analytics and industry specific
back office and front office processes. As of March 31, 2013, WNS
had 25,520 professionals across 31 delivery centers worldwide
including Costa Rica, India, Philippines, Poland, Romania, South
Africa, Sri Lanka, United Kingdom and the United States. For more
information, visit www.wns.com.
Safe Harbor StatementThis
document includes information which may constitute forward-looking
statements made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995, the accuracy of
which are necessarily subject to risks, uncertainties, and
assumptions as to future events. Factors that could cause actual
results to differ materially from those expressed or implied are
discussed in our most recent Form 20-F and other filings with the
Securities and Exchange Commission. WNS undertakes no obligation to
update or revise any forward-looking statements, whether as a
result of new information, future events, or otherwise.
WNS (NYSE:WNS)
Historical Stock Chart
From May 2024 to Jun 2024
WNS (NYSE:WNS)
Historical Stock Chart
From Jun 2023 to Jun 2024